Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Torres

Showing results (231-240 of 274) with videos related to

Pageof 28
Sort By:
Journal of the American Academy of Dermatology|September 13, 2025
Establishing consensus on defining failure of topical therapy in psoriasis: Recommendations from the International Psoriasis CouncilBruce E Strober, Andrew Blauvelt, Peter C M van de Kerkhof, et al.
Dermatology and Therapy|December 20, 2025
Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect ComparisonRaj Chovatiya, April Armstrong, Leon Kircik, et al.
European Journal of Dermatology : EJD|December 10, 2020
Portuguese recommendations for the treatment of psoriasis with biologic therapyTiago Torres, Rui Tavares Bello, Maria João Paiva Lopes, et al.
Journal of the American Academy of Dermatology|June 8, 2025
International Psoriasis Council psoriasis disease severity reclassification: Update on validity, acceptance, and implementationBruce E Strober, Andrew Blauvelt, Peter Cm van de Kerkhof, et al.
Journal of the American Academy of Dermatology|April 27, 2024
Real-world effectiveness and safety of risankizumab in adult patients with plaque psoriasis: A 1-year international multicenter retrospective cohort studyAhmed Bagit, Khalad Maliyar, Mark Mansour, et al.
Dermatology and Therapy|April 2, 2026
Retention, Effectiveness, and Safety of Secukinumab in Plaque Psoriasis: 5-Year Results from SERENAMatthias Augustin, Paul-Gunther Sator, Ralph von Kiedrowski, et al.
Journal of Cutaneous Medicine and Surgery|September 3, 2024
Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort StudyAhmed Bagit, Khalad Maliyar, Mark Mansour, et al.
The Journal of Dermatological Treatment|August 2, 2021
Patterns of dosage regimen instructions regarding topical medicines: how is the information perceived by patients?Ana Teixeira, Maribel Teixeira, Carmen Bento, et al.
Journal of Psychosomatic Research|January 10, 2022
Influence of psoriasis lesions' location and severity on psychosocial disability and psychopathology. Observational study and psychometric validation of the SAPASI Portuguese versionAna Teixeira, Cristiano Ribeiro, Rita Gaio, et al.
Journal of Immunology Research|November 26, 2015
The Protective Role of HLA-DRB1(∗)13 in Autoimmune DiseasesAndreia Bettencourt, Cláudia Carvalho, Bárbara Leal, et al.
Pageof 28

Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Journal of the American Academy of Dermatology|September 13, 2025
Establishing consensus on defining failure of topical therapy in psoriasis: Recommendations from the International Psoriasis CouncilBruce E Strober, Andrew Blauvelt, Peter C M van de Kerkhof, et al.
Dermatology and Therapy|December 20, 2025
Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect ComparisonRaj Chovatiya, April Armstrong, Leon Kircik, et al.
European Journal of Dermatology : EJD|December 10, 2020
Portuguese recommendations for the treatment of psoriasis with biologic therapyTiago Torres, Rui Tavares Bello, Maria João Paiva Lopes, et al.
Journal of the American Academy of Dermatology|June 8, 2025
International Psoriasis Council psoriasis disease severity reclassification: Update on validity, acceptance, and implementationBruce E Strober, Andrew Blauvelt, Peter Cm van de Kerkhof, et al.
Journal of the American Academy of Dermatology|April 27, 2024
Real-world effectiveness and safety of risankizumab in adult patients with plaque psoriasis: A 1-year international multicenter retrospective cohort studyAhmed Bagit, Khalad Maliyar, Mark Mansour, et al.
Dermatology and Therapy|April 2, 2026
Retention, Effectiveness, and Safety of Secukinumab in Plaque Psoriasis: 5-Year Results from SERENAMatthias Augustin, Paul-Gunther Sator, Ralph von Kiedrowski, et al.
Journal of Cutaneous Medicine and Surgery|September 3, 2024
Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort StudyAhmed Bagit, Khalad Maliyar, Mark Mansour, et al.
The Journal of Dermatological Treatment|August 2, 2021
Patterns of dosage regimen instructions regarding topical medicines: how is the information perceived by patients?Ana Teixeira, Maribel Teixeira, Carmen Bento, et al.
Journal of Psychosomatic Research|January 10, 2022
Influence of psoriasis lesions' location and severity on psychosocial disability and psychopathology. Observational study and psychometric validation of the SAPASI Portuguese versionAna Teixeira, Cristiano Ribeiro, Rita Gaio, et al.
Journal of Immunology Research|November 26, 2015
The Protective Role of HLA-DRB1(∗)13 in Autoimmune DiseasesAndreia Bettencourt, Cláudia Carvalho, Bárbara Leal, et al.
Pageof 28